While I am at it the co announced today funds will also be put towards and to commence planning for a proof of principle clinical trial in another disease indication such as Lupus,psoriasis etc etc
The Lupus market alone is estimated to be $4B by 2012;I beleive the leader of the market is currently
Human Genome Sciences with a market M/Cap of $5.18B.
Xtoll could also be used to treat
Psoriasis ?C Market est. $4.1B by 2015
Psoriatic arthritis ?C Market est. $4B 2012
Other ??Orphan Indications?? ?C attract government
re?\imbursement of up to $0.5 million per patient.
While I am at it the co announced today funds will also be put...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)